Schmitz O, Alberti K G, Christensen N J, Hasling C, Hjøllund E, Beck-Nielsen H, Orskov H
Metabolism. 1985 May;34(5):465-73. doi: 10.1016/0026-0495(85)90213-6.
A three-step hyperinsulinemic euglycemic clamp was performed in 14 nondialyzed uremic and ten age-matched healthy subjects. Nine of the uremics were restudied for a mean of 42 days (range, 21 to 88 days) after initiation of dialysis therapy. Insulin was infused at the following three rates: 0.5 mU X kg-1 X min-1, 2.0 mU X kg-1 X min-1, and 4.0 mU X kg-1 X min-1. Each dose was given for 120 minutes. Glucose uptake during the last 30 minutes of each clamp were consistently lower in uremic patients pre-dialysis than in controls (2.3 +/- 0.3 v 6.6 +/- 0.8 mg X kg-1 X min, 7.8 +/- 0.6 v 13.2 +/- 1.1 mg X kg-1 X min-1 and 9.6 +/- 0.7 v 15.5 +/- 1.0 mg X kg-1 X min-1, all P less than 0.001). Serum insulin levels were similar in the two groups, and blood glucose values during steady state were maintained at 79 +/- 2.77 +/- 2, and 77 +/- 2 mg/100 mL in uremic subjects and at 72 +/- 3, 73 +/- 2, and 75 +/- 2 mg/100 mL in healthy subjects. The insulin levels required to elicit half-maximal biological response in uremics (82 +/- 5 microU/mL) were markedly higher than in controls (54 +/- 8 microU/mL, P less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
对14例未透析的尿毒症患者和10例年龄匹配的健康受试者进行了三步高胰岛素正常血糖钳夹试验。9例尿毒症患者在开始透析治疗后平均42天(范围21至88天)进行了重新研究。胰岛素以以下三种速率输注:0.5 mU·kg⁻¹·min⁻¹、2.0 mU·kg⁻¹·min⁻¹和4.0 mU·kg⁻¹·min⁻¹。每个剂量输注120分钟。在每次钳夹试验的最后30分钟内,未透析的尿毒症患者的葡萄糖摄取量始终低于对照组(分别为2.3±0.3对6.6±0.8 mg·kg⁻¹·min⁻¹、7.8±0.6对13.2±1.1 mg·kg⁻¹·min⁻¹和9.6±0.7对15.5±1.0 mg·kg⁻¹·min⁻¹,P均<0.001)。两组的血清胰岛素水平相似,尿毒症患者稳态时的血糖值维持在79±2、77±2 mg/100 mL,健康受试者为72±3、73±2和75±2 mg/100 mL。尿毒症患者引发半数最大生物学反应所需的胰岛素水平(82±5 μU/mL)明显高于对照组(54±8 μU/mL,P<0.01)。(摘要截短至250字)